Partner

Daniel M. Scolnick is a partner in the Life Sciences group at Goodwin. Dr. Scolnick concentrates his practice in intellectual property law, including strategic patent prosecution and counseling, licensing, developing therapeutic exclusivity strategies, due diligence, and other transactional support for pharmaceutical, biotech, life sciences, and chemical companies. He is a registered patent attorney and holds a PhD in Biochemistry and Biophysics. He joined Goodwin in 2023.

Dr. Scolnick’s clients include startup and midsize biotechnology and pharmaceutical companies, venture capital groups, and Fortune 500 companies. His clients turn to him for matters that arise in the development and marketing of products in all areas of life sciences, including therapeutic antibodies, protein therapeutics, cell and gene therapy, stem cells, CAR-T, small molecules, other biologics, diagnostics, and devices.

As a PhD candidate and a post-doctoral fellow at the University of Pennsylvania, Dr. Scolnick acquired extensive experience in biochemistry, molecular biology, cell-based technologies, viral vectors, protein chemistry, and genetics. As an undergraduate, Dr. Scholnick’s research concentrated on synthetic organic chemistry where he focused on defining the structure and function of anticonvulsants by synthesizing various compounds and having them tested in  animal models. Dr. Scolnick’s experience also includes materials science work where he performed synthesis and analytical work at the University of Pennsylvania’s chemistry department as a summer fellow investigating the synthesis and purification techniques involving nanomaterials.

Dr. Scolnick has also authored eight peer-reviewed scientific articles including one that was published in the journal Nature that described the cloning and characterization of a novel cell cycle gene that has been subsequently found to be intricately involved in the progression of many cancers.

JD 2008 Villanova University Charles Widger School of Law (magna cum laude, Order of the Coif); PhD Biochemistry and Biophysics 2000 University of Pennsylvania; BA Chemistry with a concentration in Biochemistry 1995 Washington University in St. Louis